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1 Introduction 
Hospitals are an indoor environment where 
people may be especially susceptible to 
infection due to both compromised health and 
the presence of significant sources of airborne 
infectious agents (McCarthy and Spengler, 
2001).  An understanding of the characteristics 
of bioaerosol-generating processes in hospitals 
is therefore an important component in 
developing appropriate infection control 
procedures.  Such information is currently 
lacking.  To address this shortcoming, we 
quantified airborne viable bioaerosol 
concentration and its determinants in a large 
(~600 beds) teaching hospital located in 
Brisbane, Australia. 
 
2 Materials/Methods 
Several locations were assessed within the 
hospital: the Emergency Department (Fig. 1), 
Outpatient Waiting Room, Respiratory Ward 
and Lung Function (spirometry) Laboratory.  
Measurements were performed using an 
Ultraviolet Aerodynamic Particle Sizer 
(UVAPS) capable of measuring both particle 
number size distribution between 0.5 and 15 
µm, and particle fluorescence (as an indicator of 
viable bioaerosols) between 420 and 575 nm 
after being subject to an excitation wavelength 
of 355 nm.  Measurements were conducted 
continuously for four days at each location.  
Patient, staff and visitor activities proximate to 
the measurement locations were noted.   
 
An additional set of measurements were 
performed under controlled laboratory 
conditions in a flow tunnel supplied with HEPA-
filtered air to establish a fluorescence ‘signature’ 
for the major aerosol-generating processes 
observed.  Commonly used drugs administered 
via nebulisation; Salbutamol (ventolin) and 
Tobramycin, were assessed in this manner. 
 
3 Results 
The strongest particle sources identified were 
resuspension due to patient and staff activities 
(which normally comprised walking, changing 
of bedsheets, and cleaning) and nebulisation of 
various drugs.  Both produced substantial 
increases in particle number concentration above 
background levels.  The typical median diameter 
of particles generated varied, with nebulisers 
consistently producing a median size of 
approximately 1 µm, while a more variable 
spectra was observed during patient and staff 
activities.  The latter observation is likely to 
have reflected the equally variable nature of 
these activities.  Particles were most often larger 
than those produced by nebulisers.   
 
Particle fluorescence was much higher during 
patient and staff activities than use of nebulisers, 
suggesting that the former was a stronger source 
of viable bioaerosols.  This was partially 
confirmed during laboratory tests in the flow 
tunnel, which showed negligible particle 
fluorescence when the two aforementioned 
drugs were nebulised.  This result suggests that 
nebulisation of these drugs is a strong source of 
particles, but not biologically-viable material.  
However, only a limited selection of drugs were 
assessed and the role of the use of other 
nebulised pharmaceuticals in creating viable 
bioaerosols cannot be discounted.  Further 
analyses will examine this and results will be 
forthcoming.  Similarly, the role of outdoor air 
as a source of bioaerosols is currently being 
investigated, and this will permit indoor sources 
to be more easily identified and isolated. 
 
 
Figure 1 – UVAPS sampling in an unoccupied 
patient room. 
 
4 Conclusions 
Two predominant in-hospital particle sources 
have been identified to-date; namely, 
nebulisation of pharmaceuticals and re-
suspension of settled particles due to patient and 
staff activities.  Whilst both processes 
contributed significant numbers of particles, the 
latter generated the largest increase in total 
particle fluorescence, and was most marked for 
carpeted locations.  This initial result suggests 
resuspended particles constitute an important 
source of viable bioaerosols in the hospital we 
investigated.  Further analyses are on-going. 
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